Poland· PL-100290153
Zinkorot
A zinc product containing zinci orotas dihydricus, registered in Poland by Woerwag Pharma GmbH & Co. KG.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Zinci orotas dihydricus
- Manufacturer
- Woerwag Pharma GmbH & Co. KG
- Country
- Poland (PL)
- ATC code
- A12CB
- ATC class
- Zinc
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991028855
- gtin05909991028862
- gtin05909991028879
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zinci orotas dihydricus in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/231c9143-481c-43f5-94a7-3c6ff69c70fc GET /v1/drugs/231c9143-481c-43f5-94a7-3c6ff69c70fc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "25 mg Zn2+",
"packaging": "05909991028855 ¦ OTC ¦ 81093\n20 tabl.\n05909991028862 ¦ OTC ¦ 81094\n50 tabl.\n05909991028879 ¦ OTC ¦ 81095\n100 tabl.",
"substance": "Zincum 25 mg/ tabletkę (w postaci cynku orotynianu dwuwodnego) 157,36 mg/ tabletkę",
"common_name": "Zinci orotas dihydricus",
"pl_product_id": "100290153",
"pozwolenie_nr": "20762",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about zinci orotas dihydricus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.